课题基金 / 基金详情

The investigation of the mechanisms and therapy of the abnormality in antidiuretic hormone action in patients with chronic renal failure

The investigation of the mechanisms and therapy of the abnormality in antidiuretic hormone action in patients with chronic renal failure
慢性肾功能衰竭患者抗利尿激素作用异常的机制及治疗探讨
批准号:
15590852
负责人:
NONOGUCHI Hiroshi
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

NONOGUCHI Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了V1a基因敲除小鼠的肾功能和异常,发现尿浓缩能力没有异常。V1a受体基因敲除小鼠的血管加压素依赖cAMP的产生也与对照小鼠没有什么不同。现在,我们正在研究V1a受体转基因小鼠。接下来,我们研究了代谢性酸中毒大鼠尿水通道蛋白-2(AQP2)的排泄情况。代谢性酸中毒大鼠尿AQP2排泄量明显减少,但外髓集合管AQP2mRNA和蛋白表达增加。这些数据提示代谢性酸中毒时AQP2从细胞内囊泡到顶膜的转运存在异常。我们在缺钾大鼠身上观察到了同样的趋势。由于细胞内酸中毒已知发生在代谢性酸中毒和钾耗竭,细胞内酸中毒可能在减少AQP2在集合管中的运输起关键作用。我们现在正在与丹麦奥胡斯大学的尼尔森博士和美国国立卫生研究院的克努珀博士合作。
英文摘要
We investigated renal function and abnormality in V1a-knockout mice and found that there is no abnormality in urine concentrating ability. Vasopressin-dependent camp generation in V1a receptor-knockout mice was also not different from control mice. Now, we are investigating V1a receptor transgenic mice.We next investigated urinary excretion of aquaporin-2(AQP2) in rats with metabolic acidosis. Although urinary AQP2 excretion was largely decreased, AQP2 mRNA and protein in outer medullary collecting ducts were increased in rats with metabolic acidosis. These data suggest the presence of abnormality in trafficking of AQP2 from intracellular vesicle to the apical membrane in metabolic acidosis. We observed same tendency in rats with potassium depletion. Since intracellular acidosis is known to occur in metabolic acidosis and potassium depletion, intracellular acidosis may have a key role for the decreased trafficking of AQP2 in the collecting ducts. We are now collaborating with Dr, Nielsen in Aarhus University in Denmark and Dr.knepper in National Institutes of health in USA.
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1053/j.ajkd.2003.08.032
发表时间: 2003-12-01
期刊: AMERICAN JOURNAL OF KIDNEY DISEASES
影响因子: 13.2
作者: [Tanaka, M, Itoh, K, Tomita, K]
通讯作者: Tomita, K
Machida K: "Acute regulation of the eoithelial sodium channel gene by vasopressin and hyperosmolality"Hypertens Res. 26・8. 629-634 (2003)
Machida K:“加压素和高渗透压对上皮钠通道基因的急性调节”Hypertens Res 26・8(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Gene regulation of renal-osmotic stress-induced Na-Cl organic solute cotransporter.
肾渗透应激诱导的 Na-Cl 有机溶质协同转运蛋白的基因调控。
DOI: --
发表时间: 2004
期刊: Nephron Exp Nephrol 96
影响因子: --
作者: [Tuyen do G, Kitamura K, Adachi M, Miyoshi T, Wakida N, Nagano J, Nonoguchi H, Tomita K., Tuyen do G., Baba T]
通讯作者: Baba T
Angiotensin-converting enzyme inhibitor withdrawal and ACE gene polymorphism.
血管紧张素转换酶抑制剂戒断与ACE基因多态性。
DOI: --
发表时间: 2003
期刊: Clin Nephrol. 60
影响因子: --
作者: [Nonoguchi H, Kiyama S, Inoue H, Nakayama Y, Inoue T, Kohda Y, Machida K, Tajima A, Kitamura K, Miyoshi T, Shimada H, Shimada H, Tajiri M, Honda Y, Tanaka M, Tomita K.]
通讯作者: Tomita K.
21
    The mechanisms of regulation of nuclocytoplasmic transport of mineralocorticoid receptor by vasopressin V1a receptor.
    • 批准号:
      24591244
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      NONOGUCHI Hiroshi
    • 依托单位:
    The role of vasopressin V1a receptor in diabetic nephropathy and the invention of new therapy.
    • 批准号:
      21591064
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      NONOGUCHI Hiroshi
    • 依托单位:
    The investigation of the role of interaction of two types of antidiuretic hormone receptors for diuresis and the invention of the new therapy for renal edema.
    Functional analysis of antidiuretic hormone receptor using V1a knockout mice and invention of new diuretics.
    海外基金